Both Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology ...
Feeds
6046 items (6046 unread) in 74 feeds
Acinar Cell Carcinoma
(35 unread)
Acinic Cell Carcinoma
(29 unread)
Adenoid Cystic Carcinoma
(92 unread)
Adrenal Gland Cancer
(519 unread)
Ampulla Of Vater
(100 unread)
Anal Cancer
(639 unread)
Angiosarcoma
(185 unread)
Appendix Cancer
(75 unread)
Bile Duct Cancer
(692 unread)
Brain and CNS
(808 unread)
Carcinoid
(263 unread)
Endocrine/Neuroendocrine
(693 unread)
Gall Bladder Cancer
(336 unread)
Hemangioendothelioma
(39 unread)
Hepatoblastoma
(119 unread)
Pancreas
(72 unread)
Phyllodes
(43 unread)
PMP and Mucinous Tumors
(59 unread)
Rhabdomyosarcoma
(231 unread)
Sarcoma
(1017 unread)
Google - Angiosarcoma (100 unread)
1
2
-
Reviewing Conatus Pharmaceuticals Inc. (CNAT)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The FinExaminer
Posted: February 14th, 2019, 12:48pm GMT
Reviewing Conatus Pharmaceuticals Inc. (CNAT)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The FinExaminer -
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Sierra Oncology Inc. (NASDAQ:SRRA) - Lives Advice
Posted: February 13th, 2019, 3:15pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Sierra Oncology Inc. (NASDAQ:SRRA) Lives AdviceBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Sierra Oncology Inc. (NASDAQ:SRRA) are each other's competitor in the Biotechnology industry.
-
TRACON Pharmaceuticals Inc. (TCON) and Entera Bio Ltd. (NASDAQ:ENTX) Comparison side by side - EN Digest
Posted: February 13th, 2019, 2:46pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Entera Bio Ltd. (NASDAQ:ENTX) Comparison side by side EN DigestTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Entera Bio Ltd. (NASDAQ:ENTX), both competing one another are Biotechnology companies. We will ...
-
Cui Global Inc (NASDAQ:CUI) Stock Price Up as Sentiment Improves - MoneyMakingArticles
Posted: February 13th, 2019, 10:25am GMT
Cui Global Inc (NASDAQ:CUI) Stock Price Up as Sentiment Improves MoneyMakingArticlesCui Global Inc (NASDAQ:CUI) institutional sentiment increased to 1.15 in 2018 Q3. Its up 0.08, from 1.07 in 2018Q2. The ratio is more positive, as 15 hedge ...
-
Angiosarcomas Treatment Market 2018 Revenue, Growth Rate, Customer Needs, Trend, Manufacturers, and Forecast to 2026 - Crypto News Today
Posted: February 13th, 2019, 7:01am GMT
Angiosarcomas Treatment Market 2018 Revenue, Growth Rate, Customer Needs, Trend, Manufacturers, and Forecast to 2026 Crypto News TodayThe Angiosarcomas Treatment Market Research Report 2019 examines the competitive landscape , Market dynamic and discusses major trends. The report ...
-
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS | Thorold News - Thorold News
Posted: February 13th, 2019, 1:59am GMT
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS | Thorold News Thorold NewsAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
-
Reviewing NuCana plc (NCNA)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - Port Courier
Posted: February 13th, 2019, 11:18pm GMT
Reviewing NuCana plc (NCNA)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results Port CourierThis is therefore a contrasting of the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation in NuCana plc.
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Shares Bought by Renaissance Technologies LLC - Fairfield Current
Posted: February 12th, 2019, 4:08am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Shares Bought by Renaissance Technologies LLC Fairfield CurrentRenaissance Technologies LLC increased its position in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% in the 3rd quarter, according to its most ...
-
On February, 27 TRACON Pharmaceuticals, Inc. (TCON) EPS Estimated At $-0.38 - Z Tribune
Posted: February 11th, 2019, 9:55pm GMT
On February, 27 TRACON Pharmaceuticals, Inc. (TCON) EPS Estimated At $-0.38 Z TribuneOn February, 27 WallStreet anticipated TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings release, Faxor reports. Analysts have anticipation on stock's ...
-
Pacific Biosciences of California Inc. (PACB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - The FinHeadLines
Posted: February 11th, 2019, 4:26pm GMT
Pacific Biosciences of California Inc. (PACB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side The FinHeadLinesPacific Biosciences of California Inc. (NASDAQ:PACB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology ...
-
TRACON Pharmaceuticals Inc. (TCON) and Caladrius Biosciences Inc. (NASDAQ:CLBS) Comparing side by side - The FinReviewer
Posted: February 11th, 2019, 12:48pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Caladrius Biosciences Inc. (NASDAQ:CLBS) Comparing side by side The FinReviewerThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Caladrius Biosciences Inc. (NASDAQ:CLBS) based on their institutional ...
-
TRACON Pharmaceuticals Inc. (TCON) and Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) Contrasting side by side - The FinHeadLines
Posted: February 11th, 2019, 8:32am GMT
TRACON Pharmaceuticals Inc. (TCON) and Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) Contrasting side by side The FinHeadLinesAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), are affected by contrast.
-
As of February, 27 The EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 - The EN Bulletin
Posted: February 10th, 2019, 7:54pm GMT
As of February, 27 The EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 The EN BulletinTRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is expected on February, 27., Faxor reports. Analysts have anticipation on stock's earnings ...
-
Core-Mark Holding Company, Inc. (CORE) EPS Estimated At $0.30; Athenex (ATNX) Shorts Lowered By 3.81% - EN Digest
Posted: February 10th, 2019, 7:38pm GMT
Core-Mark Holding Company, Inc. (CORE) EPS Estimated At $0.30; Athenex (ATNX) Shorts Lowered By 3.81% EN DigestAnalysts expect Core-Mark Holding Company, Inc. (NASDAQ:CORE) to report $0.30 EPS on March, 7.They anticipate $0.03 EPS change or 9.09% from last ...
-
As of March, 13 The EPS for CUI Global, Inc. (CUI) Expected At $-0.06 - K Reviewer
Posted: February 8th, 2019, 1:15pm GMT
As of March, 13 The EPS for CUI Global, Inc. (CUI) Expected At $-0.06 K ReviewerDuring 2018 Q3 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News - Thorold News
Posted: February 8th, 2019, 1:31am GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News Thorold NewsAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Reduced By 6.73% Their Shorts - The EN Bulletin
Posted: February 7th, 2019, 4:24pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Reduced By 6.73% Their Shorts The EN BulletinTracon Pharmaceuticals Inc (NASDAQ:TCON) had a decrease of its short interest by 6.73%. It was published in February by FINRA the 134400 short interest on.
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Thе Mоnіtоr
Posted: February 7th, 2019, 2:39am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Thе MоnіtоrAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), are affected by ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and SELLAS Life Sciences Group Inc. (NASDAQ:SLS)'s results - EN Digest
Posted: February 7th, 2019, 11:36pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and SELLAS Life Sciences Group Inc. (NASDAQ:SLS)'s results EN DigestWe will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and SELLAS Life Sciences Group Inc. (NASDAQ:SLS) as far as ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Therapix Biosciences Ltd. (NASDAQ:TRPX) - D Minute
Posted: February 6th, 2019, 8:00pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Therapix Biosciences Ltd. (NASDAQ:TRPX) D MinuteAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Therapix Biosciences Ltd. (NASDAQ:TRPX), are affected by contrast.
-
Anticipated $-0.06 EPS for CUI Global, Inc. (CUI) as of March, 13 - Z Tribune
Posted: February 6th, 2019, 6:38pm GMT
Anticipated $-0.06 EPS for CUI Global, Inc. (CUI) as of March, 13 Z TribuneDuring 2018 Q3 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
-
Orphan Drugs Market Growth in the United States has Risen Dramatically - Industry Forecast, 2016-2022 - openPR
Posted: February 6th, 2019, 3:28pm GMT
Orphan Drugs Market Growth in the United States has Risen Dramatically - Industry Forecast, 2016-2022 openPRThe major companies in Orphan Drugs Industry include AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) - The Hi New Ulm
Posted: February 6th, 2019, 10:57am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) The Hi New UlmTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) compete with each other in the Biotechnology sector. We will ...
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 on February, 27 - The EN Bulletin
Posted: February 6th, 2019, 4:03am GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 on February, 27 The EN BulletinOn February, 27 TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is awaited by WallStreet, as reported by RTT. The EPS diference is $0.01 or ...
-
Recently Heartland Advisors Inc increased Its Position In Cui Global, Inc - The EN Bulletin
Posted: February 5th, 2019, 6:12pm GMT
Recently Heartland Advisors Inc increased Its Position In Cui Global, Inc The EN BulletinDuring Q3 2018 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Kadmon Holdings Inc. (NYSE:KDMN)'s results - The Moveefy
Posted: February 5th, 2019, 1:44pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Kadmon Holdings Inc. (NYSE:KDMN)'s results The MoveefyTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kadmon Holdings Inc. (NYSE:KDMN) are two firms in the Biotechnology that compete against each other.
-
Seres Therapeutics Inc. (MCRB)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Hi New Ulm
Posted: February 5th, 2019, 11:23am GMT
Seres Therapeutics Inc. (MCRB)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The Hi New UlmThis is a contrast between Seres Therapeutics Inc. (NASDAQ:MCRB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) based on their analyst ...
-
Angiosarcomas Treatment Market Benefit and Volume 2018 with Status and Prospect to 2026 - Oak Tribune
Posted: February 5th, 2019, 9:51am GMT
Angiosarcomas Treatment Market Benefit and Volume 2018 with Status and Prospect to 2026 Oak TribuneThe Angiosarcomas Treatment Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently released ...
-
$-0.35 EPS Expected for Teladoc Health, Inc. (TDOC); Athenex (ATNX) Shorts Lowered By 3.81% - The FinReviewer
Posted: February 4th, 2019, 7:48pm GMT
$-0.35 EPS Expected for Teladoc Health, Inc. (TDOC); Athenex (ATNX) Shorts Lowered By 3.81% The FinReviewerAnalysts expect Teladoc Health, Inc. (NYSE:TDOC) to report $-0.35 EPS on February, 26.They anticipate $0.15 EPS change or 30.00% from last quarter's $-0.5 ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and OvaScience Inc. (NASDAQ:OVAS)'s results - Port Courier
Posted: February 4th, 2019, 6:19pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and OvaScience Inc. (NASDAQ:OVAS)'s results Port CourierTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and OvaScience Inc. (NASDAQ:OVAS) have been rivals in the Biotechnology for quite some time. Below is a ...
-
On World Cancer Day - Remembering Jacob Kaplan, A Princeton Student Who Almost Made It To Graduation - Forward
Posted: February 4th, 2019, 3:18pm GMT
On World Cancer Day - Remembering Jacob Kaplan, A Princeton Student Who Almost Made It To Graduation ForwardAs we sat at the intersection of Washington and Faculty road in Princeton, New Jersey, my friend Jacob said, “You know you can make a right turn at a red light.”.
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News - Thorold News
Posted: February 4th, 2019, 12:48pm GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News Thorold NewsAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
-
Renaissance Technologies LLC Has $1.66 Million Holdings in TRACON Pharmaceuticals Inc (NASDAQ:TCON) - Fairfield Current
Posted: February 4th, 2019, 10:08am GMT
Renaissance Technologies LLC Has $1.66 Million Holdings in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Fairfield CurrentRenaissance Technologies LLC grew its holdings in shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% during the third quarter, according to ...
-
Analysts See $0.33 EPS for Solar Senior Capital Ltd. (SUNS); Tracon Pharmaceuticals (TCON) SI Decreased By 6.73% - D Minute
Posted: February 3rd, 2019, 5:22pm GMT
Analysts See $0.33 EPS for Solar Senior Capital Ltd. (SUNS); Tracon Pharmaceuticals (TCON) SI Decreased By 6.73% D MinuteAnalysts expect Solar Senior Capital Ltd. (NASDAQ:SUNS) to report $0.33 EPS on February, 21 after the close.They anticipate $0.02 EPS change or 5.71% from ...
-
TRACON Pharmaceuticals (TCON) Traded Up 10.6% - BharataPress
Posted: February 3rd, 2019, 4:02pm GMT
TRACON Pharmaceuticals (TCON) Traded Up 10.6% BharataPressShares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) were up 10.6% on Friday . The company traded as high as $0.95 and last traded at $0.94.
-
TRACON Pharmaceuticals (TCON) Trading Up 10.6% - PressOracle
Posted: February 3rd, 2019, 12:20pm GMT
TRACON Pharmaceuticals (TCON) Trading Up 10.6% PressOracleShares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) were up 10.6% on Friday . The company traded as high as $0.95 and last traded at $0.94.
-
TRACON Pharmaceuticals Inc. (TCON) and Verona Pharma plc (NASDAQ:VRNA) Comparison side by side - The Moveefy
Posted: February 3rd, 2019, 11:25am GMT
TRACON Pharmaceuticals Inc. (TCON) and Verona Pharma plc (NASDAQ:VRNA) Comparison side by side The MoveefyThis is therefore a comparing of the risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation in TRACON.
-
TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) Comparison side by side - Port Courier
Posted: February 3rd, 2019, 10:53am GMT
TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) Comparison side by side Port CourierBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Curis Inc. (NASDAQ:CRIS) are Biotechnology companies, competing one another. We will compare ...
-
Arbutus Biopharma Corporation (ABUS)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The FinReviewer
Posted: February 2nd, 2019, 1:03pm GMT
Arbutus Biopharma Corporation (ABUS)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The FinReviewerWe are contrasting Arbutus Biopharma Corporation (NASDAQ:ABUS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) on their institutional ownership, ...
-
Athenex Inc (NASDAQ:ATNX) Shorts Reduced By 3.81% As Of Feb 2, 2019 - K Reviewer
Posted: February 2nd, 2019, 11:20am GMT
Athenex Inc (NASDAQ:ATNX) Shorts Reduced By 3.81% As Of Feb 2, 2019 K ReviewerIt was reported a decrease on Athenex Inc (NASDAQ:ATNX)'s shorted shares with 3.81%. In February was announced ATNX's total 4.08M shorted shares by ...
-
Athenex Inc (NASDAQ:ATNX) Short Interest Declined By 3.81% - The EN Bulletin
Posted: February 2nd, 2019, 11:14am GMT
Athenex Inc (NASDAQ:ATNX) Short Interest Declined By 3.81% The EN BulletinIt was reported a decrease on Athenex Inc (NASDAQ:ATNX)'s short interest with 3.81%. In February was issued ATNX's total 4.08 million short interest by FINRA.
-
The veiled tumour | Arun Jaitley - THE WEEK
Posted: February 2nd, 2019, 10:05am GMT
The veiled tumour | Arun Jaitley THE WEEKIn January, Union Finance Minister Arun Jaitley left for the United States just before the crucial budget session. Despite concerns about his health and the ...
-
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS as of February, 27 - The EN Bulletin
Posted: February 2nd, 2019, 4:41am GMT
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS as of February, 27 The EN BulletinOn February, 27 WallStreet awaited TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report, according to Zacks. Analysts forecast 2.70 % diference ...
-
TRACON Pharmaceuticals (TCON) Stock Price Up 10.6% - Fairfield Current
Posted: February 2nd, 2019, 11:41pm GMT
TRACON Pharmaceuticals (TCON) Stock Price Up 10.6% Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON)'s share price rose 10.6% on Friday . The stock traded as high as $0.95 and last traded at $0.94. Approximately ...
-
Animal research saves people and their pets from cancer - The Fayette Tribune
Posted: February 1st, 2019, 2:00pm GMT
Animal research saves people and their pets from cancer The Fayette TribuneIn October, James P. Allison and Tasuku Honjo won the Nobel Prize in medicine for their groundbreaking cancer research.
-
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS on February, 27 - The EN Bulletin
Posted: February 1st, 2019, 1:25am GMT
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.38 EPS on February, 27 The EN BulletinTRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is expected by WallStreet on February, 27, as reported by RTT. Analysts expect change of ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Shorts Declined By 6.73% - The EN Bulletin
Posted: January 31st, 2019, 5:30pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Shorts Declined By 6.73% The EN BulletinTracon Pharmaceuticals Inc (NASDAQ:TCON) recorded a decrease of 6.73% in short interest. FINRA published in January TCON's total 134400 short interest.
-
TRACON Pharmaceuticals Inc. (TCON) and Ritter Pharmaceuticals Inc. (NASDAQ:RTTR) Comparison side by side - The FinExaminer
Posted: January 31st, 2019, 4:05pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Ritter Pharmaceuticals Inc. (NASDAQ:RTTR) Comparison side by side The FinExaminerTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Ritter Pharmaceuticals Inc. (NASDAQ:RTTR), both competing one another are Biotechnology companies.
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and AnaptysBio Inc. (NASDAQ:ANAB) - The Yomi Blog
Posted: January 31st, 2019, 3:47pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and AnaptysBio Inc. (NASDAQ:ANAB) The Yomi BlogBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and AnaptysBio Inc. (NASDAQ:ANAB) compete on a level playing field in the Biotechnology industry.
-
Kindred Biosciences Inc. (KIN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - Port Courier
Posted: January 31st, 2019, 10:00am GMT
Kindred Biosciences Inc. (KIN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side Port CourierKindred Biosciences Inc. (NASDAQ:KIN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector. We will ...
-
Sarcoma Coalition Launched as Collaboration of Sarcoma Advocacy Organizations - MENAFN.COM
Posted: January 31st, 2019, 11:13pm GMT
Sarcoma Coalition Launched as Collaboration of Sarcoma Advocacy Organizations MENAFN.COM(MENAFN - EIN) The Sarcoma Coalition was launched as collaboration of sarcoma advocacy organizations. Because of the rarity of this cancer, many people ...
-
Angiosarcoma After Breast Radiation — Risk is Low, but Real - Medscape
Posted: January 30th, 2019, 9:47pm GMT
Angiosarcoma After Breast Radiation — Risk is Low, but Real MedscapeThe risk of developing angiosarcoma following radiotherapy for breast cancer is low but present, and it should be treated at least with surgery, say Dutch ...
-
GDS Holdings Limited (GDS) Reaches $26.85 After 4.00% Up Move; Athenex (ATNX) Shorts Down By 3.81% - D Minute
Posted: January 30th, 2019, 6:30pm GMT
GDS Holdings Limited (GDS) Reaches $26.85 After 4.00% Up Move; Athenex (ATNX) Shorts Down By 3.81% D MinuteThe stock of GDS Holdings Limited (NASDAQ:GDS) is a huge mover today! The stock increased 5.29% or $1.35 during the last trading session, reaching $26.85.
-
How Orphan Drugs Market Became a Highly Profitable Industry: Revenue Analysis and Industry Forecast, 2016-2022 - openPR
Posted: January 30th, 2019, 12:51pm GMT
How Orphan Drugs Market Became a Highly Profitable Industry: Revenue Analysis and Industry Forecast, 2016-2022 openPRGlobal Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016-2022. Orphan ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Tiziana Life Sciences PLC (NASDAQ:TLSA)'s results - The Moveefy
Posted: January 30th, 2019, 7:41am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Tiziana Life Sciences PLC (NASDAQ:TLSA)'s results The MoveefyTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Tiziana Life Sciences PLC (NASDAQ:TLSA) have been rivals in the Biotechnology for quite some time.
-
Contrasting of aTyr Pharma Inc. (LIFE) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Hi New Ulm
Posted: January 30th, 2019, 6:00am GMT
Contrasting of aTyr Pharma Inc. (LIFE) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The Hi New UlmaTyr Pharma Inc. (NASDAQ:LIFE) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against each other.
-
Tonix Pharmaceuticals Holding Corp. (TNXP)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The FinReviewer
Posted: January 30th, 2019, 5:53am GMT
Tonix Pharmaceuticals Holding Corp. (TNXP)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The FinReviewerBoth Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Sangamo Therapeutics Inc. (NASDAQ:SGMO)'s results - The FinExaminer
Posted: January 30th, 2019, 3:13am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Sangamo Therapeutics Inc. (NASDAQ:SGMO)'s results The FinExaminerBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Sangamo Therapeutics Inc. (NASDAQ:SGMO) are each other's competitor in the Biotechnology ...
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News - Thorold News
Posted: January 30th, 2019, 11:44pm GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News Thorold NewsAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG) - D Minute
Posted: January 30th, 2019, 10:19pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG) D MinuteBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG) compete on a level playing field in the ...
-
As of February, 27 Analysts See $-0.38 EPS for TRACON Pharmaceuticals, Inc. (TCON) - K Reviewer
Posted: January 29th, 2019, 2:42pm GMT
As of February, 27 Analysts See $-0.38 EPS for TRACON Pharmaceuticals, Inc. (TCON) K ReviewerOn February, 27 WallStreet anticipated TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings release, according to Zacks. This year's EPS analyst ...
-
Renaissance Technologies LLC Acquires 88,200 Shares of TRACON Pharmaceuticals Inc (TCON) - Fairfield Current
Posted: January 28th, 2019, 10:03am GMT
Renaissance Technologies LLC Acquires 88,200 Shares of TRACON Pharmaceuticals Inc (TCON) Fairfield CurrentRenaissance Technologies LLC increased its holdings in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% in the 3rd quarter, according to its most ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Zealand Pharma A/S (NASDAQ:ZEAL) - Thе Mоnіtоr
Posted: January 28th, 2019, 8:24am GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Zealand Pharma A/S (NASDAQ:ZEAL) Thе MоnіtоrBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Zealand Pharma A/S (NASDAQ:ZEAL) are Biotechnology companies, competing one another.
-
Contrasting TRACON Pharmaceuticals (TCON) & BioCardia (BCDA) - Fairfield Current
Posted: January 28th, 2019, 6:00am GMT
Contrasting TRACON Pharmaceuticals (TCON) & BioCardia (BCDA) Fairfield CurrentTRACON Pharmaceuticals (NASDAQ:TCON) and BioCardia (OTCMKTS:BCDA) are both small-cap medical companies, but which is the better investment?
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) - The Yomi Blog
Posted: January 28th, 2019, 1:15am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) The Yomi BlogWe are comparing TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) on their risk, analyst ...
-
TRACON Pharmaceuticals Inc. (TCON) and MannKind Corporation (NASDAQ:MNKD) Contrasting side by side - The FinHeadLines
Posted: January 27th, 2019, 7:16pm GMT
TRACON Pharmaceuticals Inc. (TCON) and MannKind Corporation (NASDAQ:MNKD) Contrasting side by side The FinHeadLinesBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and MannKind Corporation (NASDAQ:MNKD) are Biotechnology companies, competing one another.
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and UroGen Pharma Ltd. (NASDAQ:URGN) - The FinExaminer
Posted: January 26th, 2019, 6:14pm GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and UroGen Pharma Ltd. (NASDAQ:URGN) The FinExaminerBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and UroGen Pharma Ltd. (NASDAQ:URGN) are Biotechnology companies, competing one another.
-
TRACON Pharmaceuticals Inc. (TCON) and Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) Contrasting side by side - The FinHeadLines
Posted: January 26th, 2019, 4:03pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) Contrasting side by side The FinHeadLinesTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Syndax Pharmaceuticals Inc. (NASDAQ:SNDX), both competing one another are Biotechnology ...
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News - Thorold News
Posted: January 26th, 2019, 3:37pm GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.38 | Thorold News Thorold NewsAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) - D Minute
Posted: January 26th, 2019, 6:00am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) D MinuteAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) are our subject to contrast ...
-
Animal research saves people and their pets from cancer - The Montgomery Herald
Posted: January 25th, 2019, 4:00pm GMT
Animal research saves people and their pets from cancer The Montgomery HeraldIn October, James P. Allison and Tasuku Honjo won the Nobel Prize in medicine for their groundbreaking cancer research.
-
Infinity Pharmaceuticals Inc. (INFI)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - D Minute
Posted: January 25th, 2019, 1:46pm GMT
Infinity Pharmaceuticals Inc. (INFI)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) D MinuteInfinity Pharmaceuticals Inc. (NASDAQ:INFI) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies.
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - The Hi New Ulm
Posted: January 25th, 2019, 2:34am GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Xenon Pharmaceuticals Inc. (NASDAQ:XENE) The Hi New UlmBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Xenon Pharmaceuticals Inc. (NASDAQ:XENE) are Biotechnology companies, competing one another ...
-
Contrasting of MediWound Ltd. (MDWD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Yomi Blog
Posted: January 25th, 2019, 11:06pm GMT
Contrasting of MediWound Ltd. (MDWD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The Yomi BlogWe are contrasting MediWound Ltd. (NASDAQ:MDWD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) on their profitability, analyst recommendations, risk ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Shorts Decreased By 6.73% - The EN Bulletin
Posted: January 24th, 2019, 7:45pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Shorts Decreased By 6.73% The EN BulletinTracon Pharmaceuticals Inc (NASDAQ:TCON) had a decrease of its shares shorted by 6.73%. FINRA issued in January TCON's total 134400 shares shorted.
-
TRACON Pharmaceuticals (TCON) Shares Traded Up 17.4% - BharataPress
Posted: January 24th, 2019, 10:06am GMT
TRACON Pharmaceuticals (TCON) Shares Traded Up 17.4% BharataPressTRACON Pharmaceuticals Inc (NASDAQ:TCON) rose 17.4% during mid-day trading on Thursday . The stock traded as high as $1.20 and last traded at $1.06.
-
Angiosarcomas Treatment Market Scrutinized in New Research 2018-2026 - Ace Newz
Posted: January 24th, 2019, 2:22am GMT
Angiosarcomas Treatment Market Scrutinized in New Research 2018-2026 Ace NewzAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Blood, Sweat and Tears? Save the Blood - Curetoday.com
Posted: January 23rd, 2019, 12:36pm GMT
Blood, Sweat and Tears? Save the Blood Curetoday.comAny cancer treatment can involve blood, sweat and tears, but did you know you could save the blood? My genetic counselor told me that saving a blood sample ...
-
Rockville Centre's Ken Pribil Jr. Foundation donates $15K for cancer research - liherald.com
Posted: January 23rd, 2019, 3:00am GMT
Rockville Centre's Ken Pribil Jr. Foundation donates $15K for cancer research liherald.comThe Ken Pribil Jr. Foundation recently made its fifth annual Sarcoma Research Grant in the amount of $15,000 to support targeted angiosarcoma cancer ...
-
Rockville Centre's Ken Pribil Jr. Foundation donates $15K for cancer research - liherald
Posted: January 23rd, 2019, 3:00am GMT
Rockville Centre's Ken Pribil Jr. Foundation donates $15K for cancer research liheraldThe Ken Pribil Jr. Foundation recently made its fifth annual Sarcoma Research Grant in the amount of $15,000 to support targeted angiosarcoma cancer ...
-
Goodbye Implant! - Curetoday.com
Posted: January 22nd, 2019, 5:02pm GMT
Goodbye Implant! Curetoday.comWe're having a snowy weekend here in Northeast Ohio. I can hear my husband shoveling the snow off the walkway to our house. When he's done shoveling, ...
-
TRACON Pharmaceuticals Inc. (TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) Comparison side by side. - The Moveefy
Posted: January 22nd, 2019, 4:30pm GMT
TRACON Pharmaceuticals Inc. (TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) Comparison side by side. The MoveefyBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) are Biotechnology companies, competing one another.
-
Agios Pharmaceuticals Inc. (AGIO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side. - EN Digest
Posted: January 22nd, 2019, 12:50pm GMT
Agios Pharmaceuticals Inc. (AGIO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side. EN DigestAs Biotechnology companies, Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our subject to contrast.
-
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma - Nasdaq
Posted: January 22nd, 2019, 10:30am GMT
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma NasdaqThree Confirmed Partial Responses by RECIST and> 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of TRC105.
-
TRACON Pharmaceuticals Announces Positive Data From Ongoing Phase 1b2 Trial Of TRC105 In Hepatocellular Carcinoma - Pharmaceutical Online
Posted: January 22nd, 2019, 6:00am GMT
TRACON Pharmaceuticals Announces Positive Data From Ongoing Phase 1b2 Trial Of TRC105 In Hepatocellular Carcinoma Pharmaceutical OnlineTRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted.
-
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma - GlobeNewswire
Posted: January 22nd, 2019, 6:00am GMT
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma GlobeNewswireThree Confirmed Partial Responses (20%) by RECIST and > 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of ...
-
Reviewing GTx Inc. (GTXI)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results. - The FinReviewer
Posted: January 22nd, 2019, 6:00am GMT
Reviewing GTx Inc. (GTXI)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results. The FinReviewerAs Biotechnology companies, GTx Inc. (NASDAQ:GTXI) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our subject to compare. And more specifically ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Flex Pharma Inc. (NASDAQ:FLKS)'s results. - D Minute
Posted: January 22nd, 2019, 4:41am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Flex Pharma Inc. (NASDAQ:FLKS)'s results. D MinuteWe are contrasting TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Flex Pharma Inc. (NASDAQ:FLKS) on their institutional ownership, profitability, risk, ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Innoviva Inc. (NASDAQ:INVA). - The Moveefy
Posted: January 21st, 2019, 9:46pm GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Innoviva Inc. (NASDAQ:INVA). The MoveefyBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Innoviva Inc. (NASDAQ:INVA) are Biotechnology companies, competing one another. We will ...
-
Applied Genetic Technologies Corporation (AGTC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side. - The FinExaminer
Posted: January 21st, 2019, 9:29pm GMT
Applied Genetic Technologies Corporation (AGTC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side. The FinExaminerAs Biotechnology companies, Applied Genetic Technologies Corporation (NASDAQ:AGTC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our ...
-
MyoKardia Inc. (MYOK) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side. - EN Digest
Posted: January 21st, 2019, 9:11pm GMT
MyoKardia Inc. (MYOK) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side. EN DigestBoth MyoKardia Inc. (NASDAQ:MYOK) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are Biotechnology companies, competing one another. We will ...
-
Ardevora Asset Management Llp Has Boosted Ralph Lauren (RL) Stake By $2.28 Million; Shorts at Athenex (ATNX) Lowered By 3.81% - The Hi New Ulm
Posted: January 21st, 2019, 3:54pm GMT
Ardevora Asset Management Llp Has Boosted Ralph Lauren (RL) Stake By $2.28 Million; Shorts at Athenex (ATNX) Lowered By 3.81% The Hi New UlmArdevora Asset Management Llp increased Ralph Lauren Corp (RL) stake by 6.67% reported in 2018Q3 SEC filing. Ardevora Asset Management Llp acquired ...
-
TRACON Pharmaceuticals (TCON) Stock Price Down 9.4% - Fairfield Current
Posted: January 20th, 2019, 2:19pm GMT
TRACON Pharmaceuticals (TCON) Stock Price Down 9.4% Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded down 9.4% during mid-day trading on Friday . The company traded as low as $0.91 and last ...
-
TRACON Pharmaceuticals (TCON) Stock Price Down 9.4% - Fairfield Current
Posted: January 20th, 2019, 2:19pm GMT
TRACON Pharmaceuticals (TCON) Stock Price Down 9.4% Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded down 9.4% during mid-day trading on Friday . The company traded as low as $0.91 and last ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Price Target Cut to $9.00 - Fairfield Current
Posted: January 20th, 2019, 6:00am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Price Target Cut to $9.00 Fairfield CurrentTRACON Pharmaceuticals (NASDAQ:TCON) had its price objective decreased by equities research analysts at BTIG Research to $9.00 in a research note ...
-
BTIG Research Lowers TRACON Pharmaceuticals (TCON) Price Target to $9.00 - Modern Readers
Posted: January 19th, 2019, 9:42pm GMT
BTIG Research Lowers TRACON Pharmaceuticals (TCON) Price Target to $9.00 Modern ReadersTRACON Pharmaceuticals (NASDAQ:TCON) had its target price dropped by investment analysts at BTIG Research to $9.00 in a research note issued to ...
-
TRACON Pharmaceuticals (TCON) Trading Up 17.4% - PressOracle
Posted: January 19th, 2019, 1:21pm GMT
TRACON Pharmaceuticals (TCON) Trading Up 17.4% PressOracleTRACON Pharmaceuticals Inc (NASDAQ:TCON) shares were up 17.4% during mid-day trading on Thursday . The stock traded as high as $1.20 and last traded ...
-
TRACON Pharmaceuticals (TCON) Price Target Cut to $9.00 by Analysts at BTIG Research - PressOracle
Posted: January 18th, 2019, 9:14pm GMT
TRACON Pharmaceuticals (TCON) Price Target Cut to $9.00 by Analysts at BTIG Research PressOracleTRACON Pharmaceuticals (NASDAQ:TCON) had its target price lowered by research analysts at BTIG Research to $9.00 in a research note issued on ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Decreased By 6.73% Their Shorts As Of Jan 18, 2019 - K Reviewer
Posted: January 18th, 2019, 6:39pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Decreased By 6.73% Their Shorts As Of Jan 18, 2019 K ReviewerIt was showed a decrease on Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s short interest with 6.73%. FINRA issued in January TCON's total 134400 short ...
-
Orphan Drugs Market Became a Highly Profitable in Pharmaceuticals Industry | By Future Industry Winners AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation And Many Others - openPR
Posted: January 18th, 2019, 2:55pm GMT
Orphan Drugs Market Became a Highly Profitable in Pharmaceuticals Industry | By Future Industry Winners AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation And Many Others openPRGlobal Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016-2022. Orphan ...
1
2